Jean-Claude J Souvie

This inventor holds 27 USPTO granted patents, plus 6 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Les Laboratoires Servier, Adir Et Compagnie, Les Laboratories Servier. Active years: 1992-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Claude J Souvie. Retrieved from https://idiyas.com/inventor/jean-claude-j-souvie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 27

% Patents Active = 74.1

CIPO Patents = 6

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 39(Granted Patents)

Location History:

Bolbec, FR (1992 - 1994)
Le Havre, FR (2000 - 2011)
Pau, FR (2010 - 2011)

Company Filing History:

19 out of 296

Les Laboratoires Servier

Les Laboratories Servier

patents

Years Active: 1992-2011

Loading Chart...

Areas of Expertise:

Agomelatine

Ivabradine

Crystalline Form

Synthesis Process

Perindopril

Pharmaceutical Compositions

Indoline

Isoindoline

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7999129 - Process for the synthesis of (7-methoxy-1-naphthyl) acetonitrile and its application in the synthesis of agomelatine (2011-08-16),

2. 7994359 - Process for the synthesis of (7-methoxy-1-naphthyl) acetonitrile and its application in the synthesis of agomelatine (2011-08-09),

3. 7939566 - Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it (2011-05-10),

4. 7923569 - β Crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it (2011-04-12),

5. 7910625 - Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it (2011-03-22),

6. 7867994 - Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid (2011-01-11),

7. 7846961 - α crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it (2010-12-07),

8. 7645905 - Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it (2010-01-12),

9. 7635721 - Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it (2009-12-22),

10. 7544839 - Process for the synthesis and crystalline form agomelatine (2009-06-09),

11. 7498466 - Process for the synthesis and crystalline form of agomelatine (2009-03-03),

12. 7498465 - Process for the synthesis and crystalline form of agomelatine (2009-03-03),

13. 7479569 - Process for the synthesis of (7-methoxy-3,4-dihydro-1-naphthalenyl) acetonitrile and its application in the synthesis of agomelatine (2009-01-20),

14. 7476751 - Process for the synthesis of (7-methoxy-1-naphthyl)acetonitrile and its application in the synthesis of agomelatine (2009-01-13),

15. 7470806 - Process for the synthesis of (7-methoxy-1-naphthyl) acetonitrile and its application in the synthesis of agomelatine (2008-12-30),

Title: Jean-Claude J Souvie: A Pioneer in Synthesis Innovation

Introduction

Jean-Claude J Souvie, based in Bolbec, France, is a distinguished inventor known for his extensive contributions to the field of chemical synthesis. With a remarkable portfolio of 27 patents, Souvie has significantly impacted pharmaceutical chemistry and related industries.

Latest Patents

Among his latest innovations, Souvie has developed a process for the synthesis of (7-methoxy-1-naphthyl) acetonitrile and its application in the synthesis of agomelatine. This groundbreaking process is intended for industrial synthesis, paving the way for more efficient production methods in pharmaceutical applications.

Career Highlights

Throughout his career, Jean-Claude Souvie has worked with prominent companies, including Les Laboratoires Servier and Adir et Compagnie. His experience in these organizations has allowed him to refine his expertise in chemical synthesis and develop innovative solutions that address industry needs.

Collaborations

Souvie has collaborated with esteemed colleagues, such as Isaac Gonzalez Blanco and Jean-Pierre Lecouve. These partnerships have fostered an environment of creativity and innovation, leading to the development of several patented processes that enhance the field of pharmaceutical chemistry.

Conclusion

Jean-Claude J Souvie's contributions to the realm of synthesis and innovation are commendable. His dedication to research and his inventive spirit continue to inspire progress within the industry, ensuring that his work will have lasting effects for years to come.

Profile summary based on public USPTO records.